These cells, known as cancer stem-like cells or tumor initiating cells (TICs), have been observed in other cancers including prostate, pancreatic, brain and leukemia [7]–[9], making CD44 an important target for cancer therapies. This evidence concerns the gene CD44 and neoplasm.